| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.003 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |